Siemens, Impac extend oncology pact:
This article was originally published in Clinica
Siemens Medical Solutions is to distribute Impac Medical Systems's Lantis oncology information system for another five years, following an extension to their long-standing agreement. Siemens has been packaging Impac's software product with its own oncology systems since 1992, when the two companies first signed the distribution contract. The agreement underlines the firms' commitment to promote an open systems environment, enabling customers to pick "best-of-breed" solutions, said Mountain View, California-based Impac, which was bought by Swedish group Elekta in April this year.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.